–
Доклады на научных конференциях
-
- 2021 The Combination of Duvelisib and Romidepsin (DR) Is Highly Active Against Relapsed/Refractory Peripheral T-Cell Lymphoma with Low Rates of Transaminitis: Final Results and Biomarker Analysis (Устный)
- Авторы: Horwitz Steven M., Nikitina Anastasia, Kotlov Nikita, Nirmal Ajit J., Xu Ran, Bagaev Alexander, Sorokina Maria, Degryse Sandrine, Moskowitz Alison J., Mehta-Shah Neha, Jacobsen Eric D., Khodadoust Michael S., Ganesan Nivetha, Drill Esther, Hancock Helen, Davey Theresa, Myskowski Patricia, Maccaro Catherine, Blouin William, Perez Leslie, Ryu Sunyoung, Galasso Natasha, Dogan Ahmet, Fowler Nathan, Kim Youn H., Weinstock David M.
- 63 Annual Meeting of the American Society of Hematology, США, 11-14 декабря 2021